Value-Based Pricing: The Good, The Bad, and The Ugly - PowerPoint PPT Presentation

About This Presentation
Title:

Value-Based Pricing: The Good, The Bad, and The Ugly

Description:

The Third Annual Medical Device Regulatory, Reimbursement ... Jeffrey C. Lerner, Ph.D. President and Chief Executive Officer. ECRI Institute. 5200 Butler Pike ... – PowerPoint PPT presentation

Number of Views:29
Avg rating:3.0/5.0
Slides: 10
Provided by: arvisno
Category:
Tags: bad | based | good | lerner | pricing | ugly | value

less

Transcript and Presenter's Notes

Title: Value-Based Pricing: The Good, The Bad, and The Ugly


1
Value-Based Pricing The Good, The Bad, and The
Ugly
  • What Does Value Mean To Hospitals?
  • March 27, 2008
  • Jeffrey C. Lerner, Ph.D.
  • President and Chief Executive Officer
  • ECRI Institute
  • 5200 Butler Pike
  • Plymouth Meeting, PA 19462

2
ECRI InstituteThe Discipline of Science. The
Integrity of Independence.
  • The Institute is an independent nonprofit that
    researches the best approaches to improving
    patient care.
  • It is designated as  an Evidence-based Practice
    Center by the U.S. Agency for Healthcare
    Research(AHRQ), and is assigned to work on
    projects on behalf of CMS. Its assessments are
    also used by Medicaid programs and private
    insurers.
  • ECRI Institutes brand and model laboratory-based
    evaluations of medical devices are used by
    thousands of hospitals and health agencies
    worldwide. The institute maintains offices in the
    U.K., Malaysia and The United Arab Emirates.
  • ECRI Institute is a Collaborating Center of the
    World Health Organization.
  • Its more than 300 staff members include
    professionals from a great variety of
    scientific/clinical disciplines, as well as from
    the legal profession, health care planning and
    business.

3
(No Transcript)
4
Provider Technology-related Processes
Strategic
Operational
Capital Budget Planning
Strategic Planning
Value Analysis
Pharmacy Therapeutics
Technology Assessment
IT Planning Committee
Medical Equipment Planning
5
Value Analysis/Technology Assessment Synergy
Strategic
Operational
- Existing- Product-centric - Cost-focus
6
TA Case Study Deep Brain Stimulation for
Parkinsons Disease
  • Key discussion points
  • Quality of life evidence
  • Medication therapy v DBS
  • Total care requirements (e.g., follow-up)
  • Cost to transition from clinical trial to
    practice
  • Result
  • Recommended approval for a defined subset of
    Parkinsons patients not Essential Tremor
    patients

7
Integrated Health Technology Decision-making
8
Some Best Practices for consideration
  • Build bridges between strategic operational
    activities
  • Strategic technology planning
  • Engage the empirical nature of physicians
  • Evidence-based data driven
  • Standardize criteria across assessment functions
    (e.g., PT, IT, TA, VAC)
  • Ensure transparency of process decisions
  • Perform retrospective reviews of decisions

9
Some Best Practices for Consideration
  • Approve key technologies by indication helps to
    limit (or begin to ID) off-label use
  • 360 assessment considerations
  • Patient safety
  • Risk management
  • Credentialing/Privileging
  • Purchasing
  • Contracting
  • Reimbursement
Write a Comment
User Comments (0)
About PowerShow.com